Adam Bloomfield, M.D., FAAP | Vice President, Medical Affairs, Rare Diseases and Pediatrics
Premier Research

Adam Bloomfield, M.D.,  FAAP, Vice President, Medical Affairs, Rare Diseases and Pediatrics, Premier Research

Dr. Adam Bloomfield oversees the Rare Diseases and Pediatrics Medical Affairs team at Premier Research. He brings to Premier extensive US and global experience in medical affairs leadership and clinical development strategy from his previous work at AstraZeneca, Sobi, and Moderna. In his current role, he provides medical monitoring oversight, therapeutic knowledge to study programs, and supports business development and consulting activities in the fields of Rare Disease and Pediatrics.  A pediatrician by training, Dr. Bloomfield has over fifteen years of clinical experience treating thousands of patients and brings a patient-centric perspective to research programs.
Dr. Bloomfield completed his pediatric residency training at New York University Medical Center. He holds a Doctor of Medicine degree from Rutgers New Jersey Medical School and a Bachelor of Science degree in mathematics from the University of Michigan – Ann Arbor. He is a fellow of the American Academy of Pediatrics and board certified by the American Board of Pediatrics.

Appearances:



Day 1- World Orphan Drug Congress USA 2025 @ 11:25

Presentation: Barriers in site identification: Navigating challenges in advanced therapy trials

Sponsored by Premier Research.

last published: 15/Jan/25 19:55 GMT

back to speakers

Get Involved At World Orphan Drug Congress USA

 

Connect with us

 
 
 
 

 

To Sponsor Or Exhibit

 
 

Justin Franks
justin.franks@terrapinn.com
t/ +1 914 819 3506

 

 

 

To Speak

 
 

Kaylee Nguyen
kaylee.nguyen@terrapinn.com
 

 

 

 

Marketing & Press

 
 

Kaylie Brogan
kaylie.brogan@terrapinn.com